.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 8,323,691

« Back to Dashboard

Details for Patent: 8,323,691

Title:Methods and apparatus for determining formulation orientation of multi-layered pharmaceutical dosage forms
Abstract: Rapid and accurate determination of the formulation orientation of multi-layer capsule-shaped tablets with respect to different internal formulation layers proximate to the opposite narrow and rounded ends of the tablets is required. By including an appropriate color scheme in multi-layer osmotic tablets, detection of the formulation orientation is achieved by detecting the color at a spot location on a side of the tablet corresponding to one or another formulation layer or to one or another interface of two formulation layers depending on the formulation orientation of the tablet.
Inventor(s): Geerke; Johan H. (Los Altos, CA), Stone; Steven F. (Saratoga, CA)
Assignee: Alza Corporation (Palo Alto, CA)
Filing Date:Mar 11, 2009
Application Number:12/402,075
Claims:1. A method of detecting the formulation orientation of a multi-layer capsule-shaped osmotic tablet comprising a first layer containing a drug ingredient and a second layer containing a drug ingredient, wherein at least one of the first and second layers comprises a first colorant; a further layer containing a second colorant that is distinguishable from the first colorant or no color, the further layer not containing any drug ingredient; wherein the first layer is located at one end of the tablet, the further layer is located at the other end of the tablet, and the second layer is located between the first layer and the further layer, such that the formulation orientation of the tablet can be determined by detecting the color at a spot location on a side of the tablet corresponding to one or another differently colored layer depending on the formulation orientation of the tablet; the method comprising the steps of: detecting the color at a spot location on a side of the tablet corresponding to one or another layer depending on the formulation orientation of the tablet; and determining the formulation orientation of the tablet on the basis of the color detected.

2. The method according to claim 1 wherein at least one of the layers contains a dark colorant.

3. The method according to claim 1 wherein one of the layers contains a dark colorant and, if one of the first and further layers contains the dark colorant, then the other of the first and further layers contains a light color.

4. A method of detecting the formulation orientation of a multi-layer capsule-shaped osmotic tablet having an end portion containing a first formulation layer that contains a drug ingredient, an opposite end portion containing a second formulation layer without a drug ingredient, and at least one intervening formulation layer with a drug ingredient, the method comprising the steps of detecting the color at a spot location on a side of the tablet corresponding to the first or second formulation layer depending on the formulation orientation of the tablet, wherein at least one of the formulation layers contains a colorant; and determining the formulation orientation of the tablet on the basis of the color detected.

5. The method according to claim 4 wherein one of the formulation layers contains a dark colorant.

6. The method according to claim 4 wherein a formulation layer without a drug ingredient contains a dark colorant and a formulation layer that contains a drug ingredient contains a light colorant.

7. A method of detecting the formulation orientation of a multi-layer capsule-shaped osmotic tablet having an end portion containing a dispensable formulation-forming layer that contains a drug ingredient, an opposite end portion containing an expanding polymer formulation layer, and an intervening layer that contains a drug ingredient, the method comprising the steps of: detecting the color at a spot location on a side of the tablet corresponding to one or another formulation layer depending on the formulation orientation of the tablet, wherein at least one of the dispensable formulation-forming layer and the expanding polymer formulation layers contains a colorant; and determining the formulation orientation of the tablet on the basis of the color detected.

8. The method according to claim 7 wherein the expanding polymer formulation layer contains a dark colorant.

9. The method according to claim 7 wherein the expanding formulation layer contains a dark colorant and the dispensable formulation-forming layer or the intervening layer contains a light colorant.

10. A method of detecting the formulation orientation of a three-layer capsule-shaped osmotic tablet having an end portion containing a first formulation layer that contains a drug ingredient, a middle portion containing a second formulation layer that contains a drug ingredient, and an opposite end portion containing a third formulation layer without a drug ingredient, the method comprising the steps of including a colorant in the first or third formulation layer of the tablet; detecting the color at a spot location on a side of the tablet corresponding to one or another differently-colored formulation layer depending on the formulation orientation of the tablet; and determining the formulation orientation of the tablet on the basis of the color detected.

11. The method according to claim 10 comprising the steps of: including a first colorant in one of the first or second formulation layers of the tablet; including a second colorant in the third formulation layer; detecting the color at a spot location on a side of the tablet corresponding to one or another differently-colored formulation layer depending on the formulation orientation of the tablet; and determining the formulation orientation of the tablet an the basis of the color detected.

12. The method of claim 11 wherein said first colorant is light and said second colorant is dark.

13. A method of detecting the formulation orientation of a three-layer capsule-shaped osmotic tablet having an end portion containing a first dispensable formulation layer, a middle portion containing a second dispensable formulation layer, and an opposite end portion containing an expandable polymer formulation layer, wherein the first and second layers contains a drug ingredient, the method comprising the steps of: including a first colorant in one of the first or second dispensable formulation layers of the tablet; including a second colorant in the third expandable polymer formulation layer; detecting the color at a spot location on a side of the tablet corresponding to one or another differently-colored formulation layer depending on the formulation orientation of the tablet; and determining the formulation orientation of the tablet on the basis of the color detected.

14. The method of claim 13 wherein said first colorant is light and said second colorant is dark.

15. A three-layer tablet comprising: first layer formulation containing a drug ingredient and a second layer containing a drug ingredient, one of the first or second layers also containing a first colorant; a third layer formulation containing a second colorant that is distinguishable from the first colorant or from no color and not containing any drug ingredient wherein the first, second and third layers are compressed into capsule-shaped osmotic tablet having the first layer formulation located at one end of the capsule-shaped osmotic tablet and the third layer formulation located at the other end of the capsule-shaped osmotic tablet and the second layer located between the first layer formulation and the third layer formulation such that the formulation orientation of the tablet can be determined by detecting the color at a spot location on a side of the tablet corresponding to one or another differently-colored formulation layer depending on the formulation orientation of the tablet and wherein the formulation orientation of the tablet is detected by a color detector directed at the spot location on the side of the tablet.

16. The tablet of claim 15 wherein the first colorant is light and the second colorant is dark.

17. The tablet of claim 16 further comprising a membrane surrounding the compressed layers through which the first and second colorant are detectable.

18. The tablet of claim 17 further comprising a delivery port drilled into the membrane at a location proximate to the first layer.

19. The tablet of claim 18 further comprising a drug overcoat applied onto the surface of the membrane.

20. A three-layer tablet comprising: a first layer formulation containing a drug ingredient and not containing any colorant; a second layer formulation containing a drug ingredient and a first colorant, the first colorant being complementary to no color; a third layer formulation containing a second colorant that is distinguishable from the first colorant or from no color and not containing any drug ingredient wherein the first, second and third layers are compressed into a capsule-shaped osmotic tablet wherein the first layer formulation is located at one end of the capsule-shaped osmotic tablet and the third layer formulation is located at the other end of the capsule-shaped osmotic tablet and the second layer is located between the first layer formulation and the third layer formulation such that the formulation orientation of the tablet can be determined by detecting the color at a spot location on a side of the tablet corresponding to one or another differently-colored formulation layer depending on the formulation orientation of the tablet; and wherein the formulation orientation of the tablet is detected by a color detector directed at the spot location on the side of the tablet.

21. The tablet of claim 20 wherein the first colorant is light and the second colorant is dark.

22. The tablet of claim 21 further comprising a membrane surrounding the compressed layers through which the first and second colorant are detectable.

23. The tablet of claim 22 further comprising a delivery port drilled into the membrane at a location proximate to the first layer.

24. The tablet of claim 23 further comprising a drug overcoat applied onto the surface of the membrane.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc